LKL International Bhd's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 81.82.
LKL International Bhd's Days Inventory for the
three
months ended in Mar. 2026 was 212.99.
LKL International Bhd's Days Payable for the
three
months ended in Mar. 2026 was 20.71.
Therefore, LKL International Bhd's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2026 was 274.10.
LKL International Bhd (XKLS:0182) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
LKL International Bhd Cash Conversion Cycle Related Terms
LKL International Bhd Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for LKL International Bhd's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0182 vs ISRG, BDX, MDLN: Cash Conversion Cycle Comparison
For the Medical Instruments & Supplies subindustry, LKL International Bhd's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LKL International Bhd Cash Conversion Cycle vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LKL International Bhd's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where LKL International Bhd's Cash Conversion Cycle falls into.
LKL International Bhd Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
LKL International Bhd's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LKL International Bhd (XKLS:0182) has a Cash Conversion Cycle of 274.10 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on LKL International Bhd and its competitors.
Is LKL International Bhd's Cash Conversion Cycle too high?
LKL International Bhd's current Cash Conversion Cycle is 274.10. The Medical Devices & Instruments industry median Cash Conversion Cycle is 156.96. LKL International Bhd's value of 274.10 is 74.6% above this industry median.
How does LKL International Bhd's Cash Conversion Cycle compare to ISRG and BDX?
LKL International Bhd's Cash Conversion Cycle of 274.10 can be compared against companies in the Medical Devices & Instruments industry. The industry median Cash Conversion Cycle is 156.96. LKL International Bhd's value of 274.10 is 74.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Medical Devices & Instruments company?
The median Cash Conversion Cycle among Medical Devices & Instruments companies is 156.96, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LKL International Bhd's current Cash Conversion Cycle of 274.10 is 74.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on LKL International Bhd and its competitors. For the Medical Devices & Instruments industry, the median Cash Conversion Cycle is 156.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LKL International Bhd's current Cash Conversion Cycle is 274.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LKL International Bhd stock overvalued right now?
Based on GuruFocus' analysis, LKL International Bhd (XKLS:0182) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.05, compared to a current price of RM0.04 — trading 30% below its estimated fair value. The current Cash Conversion Cycle is 274.10 and 74.6% above the Medical Devices & Instruments industry median of 156.96. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For LKL International Bhd (XKLS:0182), the current Cash Conversion Cycle is 274.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
LKL International Bhd is engaged in the manufacturing of medical/healthcare beds, medical peripherals and accessories as well as trading of medical furniture, medical devices, personal protective equipment, medical peripherals and accessories. The company's operating segments are Manufacturing, Trading, Retail, and Investment Holding. The Manufacturing segment is involved in the manufacturing of medical and healthcare beds, medical peripherals, and accessories, and the Trading segment is involved in the trading of medical peripherals and accessories. The company serves its products to various end users such as hospitals and medical centers, as well as other healthcare-related facilities, including clinics and specialist institutions. The majority of revenue is earned from Malaysia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0182 has been successfully added to your 